Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2012 029 350.0 |
96 | EP file number | EAKZ | 12 81 5750.0 |
86 | WO file number | WAKZ | PCT/GB2012/053113 |
97 | EP publication number | EPN | 2791163 |
87 | WO publication number | WPN | 2013088147 |
54 | Designation/title | TI | VERFAHREN ZUR T-ZELLEN EXPANSION |
51 | IPC main class | ICM (ICMV) | C12M 1/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/12 (2006.01), A61K 39/245 (2006.01), C12N 5/0783 (2010.01), A61K 39/235 (2006.01), A61K 35/17 (2025.01) |
22 | DE application date | DAT | Dec 12, 2012 |
96 | EP application date | EAT | Dec 12, 2012 |
86 | WO application date | WAT | Dec 12, 2012 |
43 | Date of first publication | OT | Jun 20, 2013 |
| Date of publication of grant | PET | Mar 1, 2017 |
71/73 | Applicant/owner | INH | AlloVir, Inc, Houston, TX, US; Baylor College of Medicine, Houston, Tex., US |
72 | Inventor | IN | KNAUS, Rainer, Ludwig, London NW1 0QG, GB; NEWTON, Katy, Rebecca, London NW1 0QG, GB |
74 | Representative | VTR | Stolmár & Partner Patentanwälte PartG mbB, 80331 München, DE |
| Address for service | | Stolmár & Partner Patentanwälte, 80331 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 201121308 Dec 12, 2011
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 14th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002791163 Searchable text:
EP000002791163 Original document:
EP000002791163B1 Searchable text:
EP000002791163B1 Original document:
EP000002791163B2 Searchable text:
EP000002791163B2 Original document:
WO002013088147 Searchable text:
WO002013088147 |
43 | Date of first publication | EVT | Jun 20, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Dec 5, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 12, 2024 (Show all update days)(Hide all update days)- Dec 12, 2024
- IPC secondary class(es): changed
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 27.11.2024: changed
- Nov 7, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 27.11.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 27.11.2024: new
- Oct 8, 2024
- Due date: changed
- Procedures: Procedure relating to PCT application, Publication of PCT application, 20.06.2013: deleted
- Oct 21, 2023; Oct 24, 2022; Oct 22, 2021; Dec 12, 2020; Nov 26, 2020; Oct 16, 2020; Jan 18, 2020; Aug 19, 2019; Feb 14, 2019; Dec 5, 2018; Aug 16, 2018; Jul 6, 2018; Jan 24, 2018; Jan 4, 2018; Oct 12, 2017; May 11, 2017; Apr 6, 2017; Mar 4, 2017; Mar 2, 2017; Aug 25, 2016
- Historical data not available for this/these date(s)
- Dec 5, 2014
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 16, 2020 |
| Issue number | HN | 48 |
| Year | PJ | 2020 |
| Publication date | VT | Nov 26, 2020 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | AlloVir, Inc, Houston, TX, US; Baylor College of Medicine, Houston, Tex., US |
71/73 | Previous applicant/owner | INHF | Baylor College of Medicine, Houston, Tex., US, Cell Medica Limited, London, GB |
| Date of update of the procedure | REGT | Nov 26, 2020 |